GlassScriptPhysician profile
Julie N Ashmun
NPI 1083824775
$2,344.74
in general payments reported to CMS, 2019-2025
27 companies · $482 in 2025
The $482 reported for 2025 was more than what 80% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18.30 · 2020: $65.87 · 2021: $93.14 · 2022: $739 · 2023: $441 · 2024: $506 · 2025: $482.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,429.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,428.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aspira Women'S Health INC | $309.48 | 2022-2024 | Ova1 |
| Shield Therapeutics INC | $281.35 | 2024-2025 | |
| Abbvie INC. | $238.12 | 2021-2023 | Lo Loestrin Fe, Orilissa |
| Ethicon US, LLC | $186.05 | 2024-2025 | Stratafix, Surgicel Nu-Knit, Ethicon |
| Stryker Corporation | $173.97 | 2025 | Clottriever Bold Catheter |
| Bayer Healthcare Pharmaceuticals INC. | $172.99 | 2020-2025 | |
| Mayne Pharma Commercial LLC | $142.83 | 2021-2025 | |
| Astellas Pharma US INC | $134.44 | 2023-2025 | Veozah |
| Pfizer INC. | $95.33 | 2022-2024 | |
| Exeltis, USA INC. | $78.59 | 2022-2024 | Slynd |
| Agile Therapeutics, INC. | $61.63 | 2021-2023 | Twirla |
| Sage Therapeutics, LLC | $60.34 | 2024-2025 | Zurzuvae |
| Channel Medsystems, INC. | $48.42 | 2023 | |
| Hologic Sales and Service, LLC | $43.99 | 2022-2024 | Acessa Provu System, Aptima |
| Roche Diagnostics Corporation | $40.99 | 2019-2020 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $37.81 | 2022 | |
| Novo Nordisk INC | $31.78 | 2022-2023 | Wegovy |
| Allergan, INC. | $28.70 | 2020 | |
| Sumitomo Pharma America, INC. | $27.77 | 2023-2024 | Myfembree |
| Avion Pharmaceuticals | $25.89 | 2022-2023 | Balcoltra |
| Evofem Biosciences, INC. | $24.56 | 2021 | |
| Gynesonics, INC. | $18.49 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Organon LLC | $17.76 | 2024 | |
| Coopersurgical, INC. | $17.23 | 2024 | Paragard T 380a |
| Mylan Pharmaceuticals INC. | $16.37 | 2022 | |
| Exact Sciences Corporation | $14.93 | 2025 | The Cologuard Plus Collection Kit |
| Therapeuticsmd, INC. | $14.93 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julie Ashmun listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.